Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
1.
AAPS PharmSciTech ; 19(3): 1160-1167, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29238945

RESUMEN

To develop a single-shot vaccine containing diphtheria toxoid (DT) with a sufficient immune response, poly(lactide-co-glycolide) (PLGA) microspheres were prepared by water-in-oil-in-water double emulsification and solvent extraction techniques using low or high-molecular-weight PLGA (LMW-MS or HMW-MS). Stearic acid (SA) was introduced to HMW-MS (HMW/SA-MS) as a release modulator. Mean particle sizes (dvs, µm) varied between the prepared microspheres, with LMW-MS, HMW-MS, and HMW/SA-MS having the sizes of 29.83, 110.59, and 69.5 µm, respectively; however, the protein entrapment and loading efficiency did not vary, with values of 15.2-16.8 µg/mg and 61-75%, respectively. LMW-MS showed slower initial release (~ 2 weeks) but faster and higher release of antigen during weeks 3~7 than did HMW-MS. HMW/SA-MS showed rapid initial release followed by a continuous release over an extended period of time (~ 12 weeks). Mixed PLGA microspheres (MIX-MS), a combination of HMW/SA-MS and LMW-MS (1:1), demonstrated a sufficient initial antigen release and a subsequent boost release in a pulsatile manner. Serum antibody levels were measured by ELISA after DT immunization of Balb/c mice, and showed a greater response to MIX-MS than to alum-adsorbed DT (control). A lethal toxin challenge test with MIX-MS (a DT dose of 18 Lf) using Balb/c mice revealed complete protection, indicating a good candidate delivery system for a single-shot immunization.


Asunto(s)
Toxoide Diftérico/administración & dosificación , Poliglactina 910/química , Animales , Toxoide Diftérico/inmunología , Femenino , Ratones , Ratones Endogámicos BALB C , Microesferas , Tamaño de la Partícula , Vacunación
2.
Biol Pharm Bull ; 40(5): 630-637, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28458348

RESUMEN

The aim of the present study was to examine the inhibitory roles and mechanisms of hirsutenone (HTN) in the regulation of osteoclastogenesis. Gene levels were compared to assure the effects of HTN on osteoclastogenesis in mouse splenocytes/CD4+ T cells, mouse macrophage-like cell line RAW264.7 (preosteoclast), MG63 (osteoblast), and RPMI1788 (B cell) cells. The mechanism by which HTN regulates the degradation of tumor necrosis factor receptor-associated factor 6 (TRAF6) and inhibits inhibitor of kappaB (IκB) and nuclear factor-kappaB (NF-κB) signaling was examined by Western blotting and luciferase reporter assays. Our results demonstrated that HTN effectively downregulated the expression of interferon γ (IFNγ), interleukin-22 (IL-22), IL-1ß, and tartrate-resistant acid phosphatase (TRAP) in splenocyte-/CD4+-RAW264.7 co-culture system. Moreover, receptor activator of nuclear factor-κB ligand (RANKL) and CD25 expression were also significantly inhibited in MG63 and CD4+ single culture system, suggesting an additional independent effect of HTN on osteoclastogenesis. Notably, TRAF6 was markedly degraded along with a decrease in nuclear factor of activated T-cells (NFATc) and NF-κB activities in RAW264.7 cells. Finally, we concluded that HTN directly or indirectly inhibits osteoclastogenesis via the inhibition of NF-κB signaling by promoting TRAF6 degradation, and plays a crucial role in suppressing the expression of RANKL and cytokines expressed in IFNγ-producing T-helper 1 (Th1) cells. These findings suggest that HTN may be a promising therapeutic candidate for diseases resulting from bone loss.


Asunto(s)
Catecoles/farmacología , Diarilheptanoides/farmacología , Interferón gamma/antagonistas & inhibidores , FN-kappa B/antagonistas & inhibidores , Osteoclastos/efectos de los fármacos , Células TH1/efectos de los fármacos , Alnus/química , Animales , Linfocitos T CD4-Positivos/metabolismo , Supervivencia Celular/efectos de los fármacos , Citocinas/antagonistas & inhibidores , Citocinas/farmacología , Ratones , Ratones Endogámicos BALB C , Osteogénesis/efectos de los fármacos , Corteza de la Planta/química , Ligando RANK/genética , Células RAW 264.7 , Transducción de Señal/efectos de los fármacos , Bazo/química , Bazo/citología , Células Madre/efectos de los fármacos , Fosfatasa Ácida Tartratorresistente/biosíntesis , Fosfatasa Ácida Tartratorresistente/genética
3.
Gen Physiol Biophys ; 35(4): 487-495, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27527723

RESUMEN

The potential risks that electromagnetic fields (EMF) pose to human physiology have been debated for several decades, especially considering that EMF is almost omnipresent and some occupations involve regular exposure to particularly strong fields. In the present study, the effects of 60 Hz 0.3 mT EMF on CD4+ T cells were evaluated. Production of T cell related cytokines, IFN-γ and IL-2, was not altered in CD4+ T cells that were exposed to EMF, and cell proliferation was also unaffected. The expression of genes present in a subset of Th17 cells was upregulated following EMF exposure, and the production of effector cytokines of the IL-17A subset also increased. To determine signaling pathways that underlie these effects, phosphorylation of STAT3 and SMAD3, downstream molecules of cytokines critical for Th17 induction, was analyzed. Increased SMAD3 phosphorylation level in cells exposed to EMF, suggesting that SMAD3 may be at least in part causing the increased Th17 cell production. Differentiation of Treg, another CD4+ T cell subset induced by SMAD3 signaling, was also elevated following EMF exposure. These results suggest that 60 Hz 0.3 mT EMF exposure amplifies TGF-ß signaling and increases the generation of specific T cell subsets.


Asunto(s)
Diferenciación Celular/fisiología , Campos Electromagnéticos , Linfocitos T Reguladores/citología , Linfocitos T Reguladores/fisiología , Células Th17/citología , Células Th17/fisiología , Animales , Diferenciación Celular/efectos de la radiación , Células Cultivadas , Citocinas/metabolismo , Relación Dosis-Respuesta en la Radiación , Masculino , Ratones , Ratones Endogámicos C57BL , Dosis de Radiación , Exposición a la Radiación , Linfocitos T Reguladores/efectos de la radiación , Células Th17/efectos de la radiación
4.
BMC Complement Altern Med ; 15: 345, 2015 10 05.
Artículo en Inglés | MEDLINE | ID: mdl-26438076

RESUMEN

BACKGROUNDS: In the present study, we aimed to examine the anti-aging properties of human placental hydrolysate (HPE) and dieckol (DE) from Ecklonia cava against free radical scavenging, muscle hypertrophy-related follistatin mRNA expression, amelioration of cognition-related genes and proteins, inhibition of collagenase-regulating genes, and elastinase activity. METHODS: The anti-aging effects were examined in human fibroblast (CCD986sk), mouse myoblast (C2C12), and neuroblastoma (N2a) cell models, by employing various assays such as 2,2-diphenyl-1-picrylhydrazyl hydrate (DPPH) scavenging, hydroxyl radical-mediated oxidation, quantitative real-time polymerase chain reaction, enzyme activity, and immunocytochemistry observation. RESULTS: Our results show that HPE combined with DE (HPE:DE) strongly scavenged DPPH radicals and protected proteins against degradation by hydroxyl radical attack. HPE:DE effectively inhibited matrix metalloproteinase-1 expression, protein kinase C alpha expression, and elastinase activity. Furthermore, HPE:DE improved the expression of cognition-related genes (choline acetyltransferase and vesicular acetylcholine transporter). These events may proactively contribute to retard the aging processes and the abrupt physiological changes probably induced by mitochondrial dysfunction with aging. CONCLUSIONS: Based on these findings, we conclude that the combined treatment of HPE:DE may be useful for anti-aging therapy in which the accumulation of oxidative damage is the main driving force.


Asunto(s)
Envejecimiento/efectos de los fármacos , Benzofuranos/farmacología , Phaeophyceae/química , Placenta/química , Hidrolisados de Proteína/farmacología , Envejecimiento/genética , Envejecimiento/metabolismo , Animales , Línea Celular , Femenino , Depuradores de Radicales Libres/farmacología , Humanos , Metaloproteinasa 1 de la Matriz/genética , Metaloproteinasa 1 de la Matriz/metabolismo , Ratones , Estrés Oxidativo/efectos de los fármacos , Embarazo , Proteína Quinasa C-alfa/genética , Proteína Quinasa C-alfa/metabolismo , Especies Reactivas de Oxígeno/metabolismo
5.
Biol Pharm Bull ; 37(5): 826-33, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24599032

RESUMEN

In Alzheimer's disease (AD), extensive neuronal loss and a deficiency of the neurotransmitter acetylcholine (ACh) are the major characteristics during pathogenesis in the brain. In the present study, we aimed to investigate whether representative ginsenosides from ginseng can regulate choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT), which are required for cholinergic neurotransmission. Our results revealed that Re and Rd induced effectively the expression of ChAT/VAChT genes in Neuro-2a cells as well as ACh elevation. Microtubule-associated protein-2 (MAP-2), nerve growth factor receptor (p75), p21, and TrkA genes and proteins were also significantly expressed. Moreover, both activated extracelullar signal-regulated protein kinase (ERK) and Akt were inhibited by K252a, a selective Trk receptor inhibitor. These findings strongly indicate that Re and Rd play an important role in neuronal differentiation and the nerve growth factor (NGF)-TrkA signaling pathway. High performance liquid chromatography analysis showed that Re and Rd administered orally were transported successfully into brain tissue and increased the level of ChAT and VAChT mRNA. The present study demonstrates that Re and Rd are selective candidates for upregulation of the expression of cholinergic markers, which may counter the symptoms and progress of AD.


Asunto(s)
Acetilcolina/biosíntesis , Diferenciación Celular/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Ginsenósidos/farmacología , Neuronas/citología , Neuronas/efectos de los fármacos , Animales , Biomarcadores/metabolismo , Línea Celular , Colina O-Acetiltransferasa/biosíntesis , Ginsenósidos/farmacocinética , Ratones , Proteínas Asociadas a Microtúbulos/biosíntesis , Neuronas/metabolismo , Receptor de Factor de Crecimiento Nervioso/biosíntesis , Receptor trkA/biosíntesis , Proteínas de Transporte Vesicular de Acetilcolina/biosíntesis , Proteínas de Unión al GTP rho/biosíntesis
6.
Phytother Res ; 25(9): 1301-5, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21312305

RESUMEN

The roots of Rhododendron mucronulatum Turzaninov have been used in Oriental traditional medicine for the treatment of dysuria, fever, increase of digestive activity and tonics in China and Korea. Activity guided isolation of the roots of Rhododendron mucronulatum Turzaninov has led to the isolation of three flavonoids, one flavan 3-ol and one proanthocyanidin. Chemical investigation of the 80% Me2 CO extract from the roots of Rhododendron mucronulatum led to the isolation and identification of five compounds: taxifolin (1), taxifolin 3-O-ß-D-glucopyranoside (2), quercetin 3-O-α-L-arabinofuranoside (3), (-)-epicatechin (4), procyanidin B-3 (5). To investigate the antioxidative and antiinflammatory effects of these compounds, their 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activities and the protein levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in LPS-stimulated HaCaT cells were also quantified by western blotting and their end products, nitric oxide (NO) and prostaglandin E2 (PGE2 ), respectively. Compounds (1-5) showed potent DPPH radical scavenging compared with positive controls (L-ascorbic acid). Also, compounds 1 and 2 dose-dependently inhibited the expressions of inflammatory mediators, NO and PGE2 , suggesting they are promising candidates as antiinflammatory agents.


Asunto(s)
Inhibidores de la Ciclooxigenasa/farmacología , Óxido Nítrico Sintasa de Tipo II/antagonistas & inhibidores , Extractos Vegetales/farmacología , Rhododendron/química , Antiinflamatorios/farmacología , Antioxidantes/farmacología , Arabinosa/análogos & derivados , Arabinosa/farmacología , Biflavonoides/farmacología , Catequina/farmacología , Línea Celular , Ciclooxigenasa 2/metabolismo , Dinoprostona/metabolismo , Glucósidos/farmacología , Humanos , Óxido Nítrico/metabolismo , Raíces de Plantas/química , Proantocianidinas/farmacología , Quercetina/análogos & derivados , Quercetina/farmacología
7.
Phytother Res ; 25(10): 1564-9, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21717518

RESUMEN

Recently, the isolation of several condensed tannins from the roots of Rosa multiflora Thunberg, a traditional herbal therapy in oriental medicine for rheumatoid arthritis and scabies, was described. Two of the major condensed tannins - procyanidin B-3 (ProB3) and ent-guibourtinidol-(4ß â†’ 6)-catechin (RM-1) - were then applied topically to atopic dermatitis-like skin lesions on NC/Nga mice in order to assess their immunomodulatory properties. Both ProB3 and RM-1 significantly reduced the serum levels of eosinophils, IgE and certain Th2 cytokines (IL-4, 5 and 13) (p < 0.05 or 0.01). Additionally, ProB3 and RM-1 significantly reduced both the mRNA and protein expression of COX-2 and iNOS in mouse skin tissues (p < 0.01). Such results strongly suggest that ProB3 and RM-1 may be useful in the treatment allergic skin conditions, most notably atopic dermatitis.


Asunto(s)
Biflavonoides/uso terapéutico , Catequina/uso terapéutico , Dermatitis Atópica/tratamiento farmacológico , Factores Inmunológicos/farmacología , Fitoterapia , Extractos Vegetales/uso terapéutico , Proantocianidinas/uso terapéutico , Rosa/química , Administración Tópica , Animales , Biflavonoides/farmacología , Catequina/análogos & derivados , Catequina/farmacología , Inhibidores de la Ciclooxigenasa/farmacología , Inhibidores de la Ciclooxigenasa/uso terapéutico , Citocinas/sangre , Dermatitis Atópica/inmunología , Dermatitis Atópica/metabolismo , Eosinófilos/metabolismo , Femenino , Inmunoglobulina E/sangre , Factores Inmunológicos/uso terapéutico , Ratones , Ratones Endogámicos , Óxido Nítrico Sintasa de Tipo II/metabolismo , Extractos Vegetales/farmacología , Raíces de Plantas , Proantocianidinas/farmacología , ARN Mensajero/metabolismo , Piel/efectos de los fármacos , Piel/inmunología , Piel/patología , Células Th2/metabolismo
8.
Exp Dermatol ; 19(8): e37-43, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19849716

RESUMEN

The diarylheptanoid, oregonin (ORE), which was isolated from the bark of Alnus japonica Steudel that grows natively in Korea, has been known to exert antioxidative, anti-inflammatory, anti-cancer and immune response inhibitory effects. The antioxidative effect of ORE was observed on the superoxide and 1,1-diphenyl-2-picrylhydrazyl radical, as well as on the expression of inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-treated RAW264.7 macrophages. The statistically significant inhibitory action of ORE against production of cytokines induced by bacterial products or by interleukin (IL)-1beta, free radicals and nitrogen species, and a corresponding increase in cellular calcium concentration because of ORE were confirmed in bone marrow and spleen dendritic cells that are known to play important functions in the development and advancement of atopic dermatitis (AD). It was thus expected that ORE would exert a beneficial effect in the treatment of AD. A study on the pharmaceutical benefits of ORE against AD has not yet been conducted in vivo. We therefore used an in vivo AD animal model, namely the NC/Nga mice, and by applying ORE onto the animals through skin application as well as intraperitoneal injection, we attempted to evaluate the benefits of ORE in this system. Evaluation of ORE was conducted by following the SCORE method to score the effect, as well as by measuring the Th2 cytokines IL-4, IL-5 and IL-13 levels from serum and lymphocytes, and IgE and eosinophil levels from serum. Additionally, the expression of mRNA and protein levels was estimated using real-time polymerase chain reaction and Western blotting analysis. The following categories of clinical evaluation, Th2 cytokines IL-4, IL-5 and IL-13 values, serum IgE levels, serum eosinophil levels, and mRNA and protein expression levels of iNOS and COX-2, were evaluated from topical application and intraperitoneal injection groups of ORE. The effects of ORE on AD in NC/Nga mice were confirmed as being similar to the positive control group, while a significant difference with the negative control group was observed. The results presented in this report suggest that ORE might be beneficial in the treatment of AD.


Asunto(s)
Alnus , Dermatitis Atópica/tratamiento farmacológico , Diarilheptanoides/administración & dosificación , Diarilheptanoides/uso terapéutico , Extractos Vegetales/administración & dosificación , Extractos Vegetales/uso terapéutico , Administración Tópica , Animales , Ciclooxigenasa 2/metabolismo , Citocinas/metabolismo , Dermatitis Atópica/metabolismo , Modelos Animales de Enfermedad , Femenino , Inmunoglobulina E/sangre , Inyecciones Intraperitoneales , Ratones , Ratones Endogámicos , Óxido Nítrico Sintasa de Tipo II/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Resultado del Tratamiento
9.
Clin Dev Immunol ; 2010: 618517, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21197410

RESUMEN

Atopic dermatitis (AD) is a common inflammatory skin disease. The increasing prevalence and severity of AD have prompted the developments of safer, more effective drugs. Although topical corticosteroids have been used as first line therapy for AD, their potential side effects limit their clinical applications. To investigate the effect of hirsutenone (HIR), a diarylheptanoid compound, on AD-like skin lesions and other factors related to immune response is the aim of this paper Th2-related cytokines (IL-4, IL-5, IL-13), eosinophil, IgE inflammatory factors (COX-2, iNOS) levels were reduced in blood, lymphocytes, and tissue after HIR treatment. These results suggest that HIR might be an effective treatment for AD.


Asunto(s)
Catecoles/uso terapéutico , Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/patología , Diarilheptanoides/uso terapéutico , Piel/patología , Administración Cutánea , Animales , Catecoles/administración & dosificación , Catecoles/síntesis química , Ciclooxigenasa 2/sangre , Diarilheptanoides/administración & dosificación , Diarilheptanoides/síntesis química , Diarilheptanoides/aislamiento & purificación , Modelos Animales de Enfermedad , Eosinófilos/efectos de los fármacos , Femenino , Inmunoglobulina E/sangre , Inyecciones Intraperitoneales , Interleucinas/sangre , Ratones , Ratones Endogámicos , Óxido Nítrico Sintasa de Tipo II/sangre
10.
Biol Pharm Bull ; 33(11): 1854-60, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21048311

RESUMEN

In pancreatic islets, free radical formation produced upon exposure to proinflammatory cytokines mediates ß cell destruction, which ultimately leads to type 1 diabetes (T1D). In this study, we examined whether laccase, a family of the blue copper protein, can be successfully used to prevent ß cells from cytokine-mediated apoptosis. Non-obese diabetic (NOD) mice were used for these experiments. In parallel, the RINm5f ß cell line was employed as a model system for in vitro experiments. The results demonstrated that laccase effectively scavenged peroxinitrite, which can be formed by nitric oxide, and upregulated the expression of antioxidant enzymes, such as manganese superoxide dismutase (MnSOD) and catalase. Interestingly, laccase balanced pro- (Bax) and anti-apoptotic (Bcl-2) proteins in terms of both the mRNA and protein levels with a downregulation of cytochrome c protein in RINm5f cells. In addition, laccase maintained blood glucose concentrations at a normal level with a simultaneous increase in plasma insulin levels during the spontaneous induction of diabetes in NOD mice. In conclusion, the antioxidant potentials of laccase in scavenging free radicals and upregulation of antioxidant enzymes may exert its pro-survival effect by counteracting the increased intracellular oxidative stress, and, consequently, by inhibiting apoptosis induced by cytokine-mediated activation during the course of T1D.


Asunto(s)
Antioxidantes/farmacología , Apoptosis/efectos de los fármacos , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Células Secretoras de Insulina/efectos de los fármacos , Lacasa/farmacología , Estrés Oxidativo/efectos de los fármacos , Polyporales/química , Animales , Antioxidantes/metabolismo , Antioxidantes/uso terapéutico , Glucemia/metabolismo , Citocromos c/metabolismo , Citocinas/metabolismo , Diabetes Mellitus Tipo 1/metabolismo , Femenino , Insulina/sangre , Células Secretoras de Insulina/fisiología , Lacasa/uso terapéutico , Ratones , Ratones Endogámicos NOD , Ácido Peroxinitroso/metabolismo , Fitoterapia , Ratas , Regulación hacia Arriba , Proteína X Asociada a bcl-2/genética , Proteína X Asociada a bcl-2/metabolismo
11.
Biochem Cell Biol ; 87(6): 943-52, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19935880

RESUMEN

In this study, we determined the antioxidant activities of two different solvent fractions(butanol and hexane) obtained from white Rosa rugosa flowers by employing various assays such as 2,2-diphenyl-1-picrylhydrazyl hydrate (DPPH), 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) radical scavenging activity, and nitric oxide (NO) scavenging and inhibition activity in S-nitroso-N-acetylpenicillamine (SNAP) in the RAW264.7 model. In addition, more advanced antioxidant assays were conducted, including lipid peroxidation, hydroxyl radical-mediated oxidation, DNA fragmentation, apoptosis, and cell growth. The results revealed that the hexane fraction, which contained a significant amount of polyphenols and volatile components, had excellent antioxidant potency and could scavenge free radicals of DPPH and ABTS. Interestingly, the hexane fraction inhibited lipid peroxidation to almost the same degree as a chemical antioxidant. In the NO assay, the hexane fraction effectively scavenged free radicals at all dose ranges and is expected to inhibit NO production in mammalian cells. The hexane fraction effectively prevented oxidative damage, which was induced by Cu2+/H2O2, to target proteins at lower concentrations (>1 microg x mL(-1)). The DNA fragmentation and the cell-level assays suggest that the hexane fraction may play a crucial role in inhibiting peroxynitrite and H2O2 attack. Based on the findings described in this study, the hexane fraction holds promise for use as a novel pharmaceutical antioxidant.


Asunto(s)
Antioxidantes/química , Flores/química , Depuradores de Radicales Libres/química , Hexanos/química , Extractos Vegetales/química , Rosa/química , Animales , Antioxidantes/farmacología , Benzotiazoles/química , Compuestos de Bifenilo/química , Línea Celular , Cromatografía Líquida de Alta Presión , Depuradores de Radicales Libres/farmacología , Cromatografía de Gases y Espectrometría de Masas , Indicadores y Reactivos/química , Peroxidación de Lípido/efectos de los fármacos , Masculino , Ratones , Óxido Nítrico/metabolismo , Fenoles/química , Picratos/química , Ratas , Ratas Sprague-Dawley , Rosa/anatomía & histología , Solventes/química , Ácidos Sulfónicos/química
12.
Phytother Res ; 23(7): 913-9, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19145636

RESUMEN

The use of herbal medicines in the therapeutic treatment of atopic dermatitis (AD) has been suggested recently. The present study examined whether selected herbal extracts fermented in Lactobacillus plantarum (FHE) possessed anti-AD properties. In addition, the study assessed the increased bioavailability of these herbal extracts both in vitro and in vivo. The data from these experiments revealed that FHE inhibited the proliferation of splenic T and B cells in a dose-dependent manner, when activated with their mitogens. Moreover, the expression of Th1/Th2 mRNA cytokines (IL-2, IL-4, IL-5, IL-13) from mouse splenocytes was inhibited severely as was cyclosporine A. Furthermore, the release of beta-hexosaminidase in RBL-2H3 mast cells was suppressed significantly. FHE also reduced the plasma level of IgE in dust mite extract-induced AD-like NC/Nga mice. More dramatic results were found in the histological changes, which were observed by hematoxylin-eosin and toluidine blue staining, as well as in the macroscopic features on dorsal lesions of AD-like NC/Nga mice. In conclusion, the results presented in this study suggest that FHE may have therapeutic advantages for the treatment of AD due to its increased immune-suppressive and increased absorptive effects, which were fortified by L. plantarum fermentation.


Asunto(s)
Dermatitis Atópica/tratamiento farmacológico , Inmunosupresores/farmacología , Lactobacillus plantarum/metabolismo , Extractos Vegetales/farmacología , Administración Tópica , Animales , Línea Celular , Proliferación Celular/efectos de los fármacos , Cromatografía Líquida de Alta Presión , Citocinas/metabolismo , Modelos Animales de Enfermedad , Fermentación , Medicina de Hierbas , Inmunoglobulina E/sangre , Masculino , Ratones , Plantas Medicinales , Piel/patología , Bazo/citología , Bazo/metabolismo , Células TH1/efectos de los fármacos , Células TH1/metabolismo
13.
Mol Cells ; 25(1): 112-8, 2008 Feb 29.
Artículo en Inglés | MEDLINE | ID: mdl-18319622

RESUMEN

Laccases are multicopper-containing oxidases that catalyze the oxidation of many aromatic compounds with concomitant reduction of oxygen to water. Interest in this enzyme has arisen in many fields of industry, including detoxification, wine stabilization, paper processing, and enzymatic conversion of chemical intermediates. In this study, we cloned a laccase gene (GLlac1) from the white-rot fungus Ganoderma lucidum. The cloned gene consists of 4,357 bp, with its coding region interrupted by nine introns, and the upstream region has putative CAAT and TATA boxes as well as several metal responsive elements (MREs). We also cloned a full-length cDNA of GLlac1, which contains an uninterrupted open reading frame (ORF) of 1,560 bp coding for 520 amino acids with a putative 21-residue signal sequence. The DNA and deduced amino acid sequences of GLlac1 were similar but not identical to those of other fungal laccases. GLlac1 was released from the cells when expressed in P. pastoris, and had high laccase activity. In addition, GLlac1 conferred antioxidative protection from protein degradation, and thus may be useful in bio-medical applications.


Asunto(s)
Antioxidantes/metabolismo , Proteínas Fúngicas , Lacasa , Reishi/enzimología , Secuencia de Aminoácidos , Secuencia de Bases , Clonación Molecular , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Lacasa/genética , Lacasa/metabolismo , Datos de Secuencia Molecular
14.
Phytother Res ; 22(3): 335-9, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17926337

RESUMEN

Acne is a typical condition of adolescence and is caused by multi-factorial events including hormonal, microbiological and immunological mechanisms. Although there has been much debate about the direct involvement of bacteria, Propionibacterium acnes is now believed to contribute to the inflammatory stages of the condition, and thus initiate the inflamed lesion. The present study examined the anti-acne properties of the Selaginella involvens extract (SIE) in cell models. Primarily, SIE was not found to be cytotoxic under 50 microg/mL, and revealed the inhibitory effect on both nitric oxide (NO) production and iNOS/IL-1beta expression as well as the NO scavenging effect. The IL-1alpha and IL-8 cytokines, triggering the inflammatory acne response, were also inhibited in keratinocytes when stimulated with viable P. acnes. Furthermore, SIE was found to have an antioxidant effect in a dose-dependent manner in the hydroxyl radical-mediated oxidation test. Finally, it was found that SIE has non-antibiotic antimicrobial activity at a dose greater than 100 microg/mL on P. acnes. In conclusion, SIE may be a safe non-antibiotic anti-acne source in the therapeutic application of the treatment of acne development by reducing the chance of non-specific initiation and augmentation phase of the inflammatory response.


Asunto(s)
Acné Vulgar/tratamiento farmacológico , Antioxidantes/farmacología , Fitoterapia , Extractos Vegetales/farmacología , Selaginellaceae/química , Animales , Línea Celular , Relación Dosis-Respuesta a Droga , Expresión Génica/efectos de los fármacos , Humanos , Interleucinas/análisis , Interleucinas/biosíntesis , Queratinocitos/efectos de los fármacos , Lipopolisacáridos/farmacología , Macrófagos/efectos de los fármacos , Ratones , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa de Tipo II/análisis , Óxido Nítrico Sintasa de Tipo II/biosíntesis , Propionibacterium acnes/efectos de los fármacos , Propionibacterium acnes/crecimiento & desarrollo
15.
Arch Pharm Res ; 29(5): 405-11, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16756086

RESUMEN

Biphenyl dimethyl dicarboxylate (DDB) is a hepatoprotectant, which is used as an adjuvant agent in a treatment for chronic hepatitis. Amantadine is an antiviral agent, which is utilized primarily in the treatment of influenza, but also, occasionally in the treatment of hepatitis C. In a previous study, we reported that DDB, coupled with amantadine, would exert an anti-HBV effect, via the induction of interferon-inducible gene expression in the HepG2 2.2.15 cell line. The primary objective of the present study was to determine whether or not DDB and/or amantadine exhibit anti-HBV properties, and what mechanisms of action might be involved in such properties. In our study, we were able to determine that DDB stimulates Jak/Stat signaling, and induces the expression of interferon alpha (IFN-alpha) stimulated genes, most notably 6-16 and ISG12. In addition, the antiviral effectors induced by IFN-alpha, PKR, OAS, and MxA, were regulated in the presence of DDB at its optimal concentration (250 microg/mL), to a degree commensurate with the degree of induction associated with the IFN-alpha treated group. Finally, we determined that the replication of pregenomic RNA and HBeAg was inhibited by DDB treatment, and this inhibition was maximized when coupled with the administration of amantadine (25 microg/mL). In conclusion, the results of this study demonstrated clearly that DDB, as well as the combination of DDB/amantadine, directly inhibited IFN-alpha signaling-mediated replication of HBV in infected hepatocytes, and thus may represent a novel treatment for chronic hepatitis B, which would be characterized principally by its improved safety over other treatment strategies.


Asunto(s)
Amantadina/farmacología , Antivirales/farmacología , Dioxoles/farmacología , Virus de la Hepatitis B/efectos de los fármacos , Hepatocitos/efectos de los fármacos , Transducción de Señal , Amantadina/toxicidad , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Sinergismo Farmacológico , Regulación de la Expresión Génica/efectos de los fármacos , Virus de la Hepatitis B/genética , Virus de la Hepatitis B/aislamiento & purificación , Hepatocitos/enzimología , Hepatocitos/virología , Humanos , Interferón-alfa/biosíntesis , Interferón-alfa/farmacología , Proteínas de la Membrana/biosíntesis , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Proteínas Mitocondriales/biosíntesis , Proteínas Mitocondriales/genética , Proteínas Mitocondriales/metabolismo , ARN Mensajero/metabolismo , ARN Viral/metabolismo , Receptor de Interferón alfa y beta , Receptores de Interferón/biosíntesis , Receptores de Interferón/genética , Receptores de Interferón/metabolismo , Factores de Tiempo , Replicación Viral/efectos de los fármacos
16.
Arch Pharm Res ; 39(5): 705-12, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-27071615

RESUMEN

T cells play an important role in adaptive immune responses that destroy pathogens or infected cells. Therefore, regulation of T cell activity is important in various diseases, such as autoimmune diseases, hypersensitivity, and cancer. The conjugation of small ubiquitin-related modifier (SUMO) is a post-translational protein modification that regulates activity, stability, and subcellular translocation of target proteins. In this study, CD8(+) T cells overexpressing SUMO2 showed greater proliferation and cytotoxic activity against tumor cells in the presence of IL-6 than wild-type CD8(+) T cells in vitro. These CD8(+) T cell functions were suppressed during treatment with MEK1 or PI3K-specific inhibitors. Therefore, our findings suggest that IL-6-derived signaling pathways, including the MEK1 and PI3K pathways, are upregulated by SUMO2 overexpression. However, transgenic expression of SUMO2 in T cells did not modulate Th1/2 balance. Collectively, our results showed that SUMO2-Tg promotes cytotoxic activity against tumor cells by increasing the proliferation and cytotoxicity of CD8(+) T cells.


Asunto(s)
Linfocitos T CD8-positivos/inmunología , Proliferación Celular , Interleucina-6/inmunología , Proteínas Modificadoras Pequeñas Relacionadas con Ubiquitina/genética , Inmunidad Adaptativa , Animales , Linfocitos T CD8-positivos/citología , Linfocitos T CD8-positivos/metabolismo , Técnicas de Cultivo de Célula , Línea Celular Tumoral , Supervivencia Celular/inmunología , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/inmunología , Diabetes Mellitus Tipo 1/sangre , Diabetes Mellitus Tipo 1/inmunología , Inmunoglobulina E/sangre , Interleucina-6/farmacología , Activación de Linfocitos/inmunología , MAP Quinasa Quinasa 1/metabolismo , Masculino , Ratones Endogámicos C57BL , Ratones Transgénicos , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Modificadoras Pequeñas Relacionadas con Ubiquitina/inmunología , Linfocitos T Citotóxicos/citología , Linfocitos T Citotóxicos/inmunología , Linfocitos T Citotóxicos/metabolismo
17.
Artículo en Inglés | MEDLINE | ID: mdl-27110266

RESUMEN

It is well recognized that regulating the hair follicle cycle in association with Wnt signaling is one of the most interesting targets for promoting hair regrowth. In this study, we examined whether selected herbal medicines processed by decoction and fermentation promote hair growth by upregulating the number and size of hair follicles and Wnt signaling, including activation of ß-catenin and Akt in telogen-synchronized C57BL/6N mice. The results revealed that the fermented extract after decoction (FDE) more effectively promoted hair growth than that of a nonfermented extract (DE). Notably, FDE effectively enhanced formation of hair follicles with clearer differentiation between the inner and outer root sheath, which is observed during the anagen phase. Mechanistic evidence was found for increased ß-catenin and Akt phosphorylation levels in dorsal skin tissue along with elevated expression of hair regrowth-related genes, such as Wnt3/10a/10b, Lef1, and fibroblast growth factor 7. In conclusion, our findings suggest that FDE plays an important role in regulating the hair cycle by increasing expression of hair regrowth-related genes and activating downstream Wnt signaling targets.

18.
Int Immunopharmacol ; 32: 125-132, 2016 03.
Artículo en Inglés | MEDLINE | ID: mdl-26828762

RESUMEN

Macrophages are archetypal innate immune cells that play crucial roles in the recognition and phagocytosis of invading pathogens, which they identify using pattern recognition receptors (PRRs). Dectin-1 is essential for antifungal immune responses, recognizing the fungal cellular component ß-glucan, and its role as a PRR has been of increasing interest. Previously, we discovered and characterized a novel biaryl amide compound, MPS 03, capable of inhibiting macrophage phagocytosis of zymosan. Therefore, in this study we aimed to identify other biaryl amide compounds with greater effectiveness than MPS 03, and elucidate their cellular mechanisms. Several MPS 03 derivatives were screened, four of which reduced zymosan phagocytosis in a similar manner to MPS 03. To establish whether such phagocytosis inhibition influenced the production of inflammatory mediators, pro-inflammatory cytokine and nitric oxide (NO) levels were measured. The production of TNF-α, IL-6, IL-12, and NO was significantly reduced in a dose-dependent manner. Moreover, the inflammation-associated MAPK signaling pathway was also affected by biaryl amide compounds. To investigate the underlying cellular mechanism, PRR expression was measured. MPS 03 and its derivatives were found to inhibit zymosan phagocytosis by decreasing Dectin-1 expression. Furthermore, when macrophages were stimulated by zymosan after pretreatment with biaryl amide compounds, downstream transcription factors such as NFAT, AP-1, and NF-κB were downregulated. In conclusion, biaryl amide compounds reduce zymosan-induced inflammatory responses by downregulating Dectin-1 expression. Therefore, such compounds could be used to inhibit Dectin-1 in immunological experiments and possibly regulate excessive inflammatory responses.


Asunto(s)
Amidas/farmacología , Antiinflamatorios/farmacología , Lectinas Tipo C/metabolismo , Macrófagos/efectos de los fármacos , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Citocinas/metabolismo , Lectinas Tipo C/genética , Macrófagos/metabolismo , Ratones , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Óxido Nítrico/metabolismo , Fagocitosis/efectos de los fármacos , Zimosan
19.
Arch Pharm Res ; 28(4): 451-7, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15918519

RESUMEN

Experimental studies have demonstrated that the triple combination of amantadine (A)/ ursodeoxycholic acid (UDCA, U)/ biphenyl dimethyl dicarboxylate (DDB, D) might have a preferential antiviral effect compared with that observed in interferon-induced antiviral signal pathways, such as those of STAT1alpha and the 6-16 genes. To confirm the result, this study examined whether the signal transduction for the antiviral activity in HepG2 2.2.15 was induced dependently or independently of interferon. To accomplish this, the correlation between the STAT1alpha and 6-16 genes, and nitric oxide, for the mediation of the antiviral activity was assessed. The increase in nitric oxide in the UDCA groups suggests that the inhibition of viral gene replication was enhanced by the amantadine combinations (AU and AUD), and might be more effective if incubated for longer periods. It was found that STAT1alpha was activated by the amantadine combination, although to a lesser extent than that of interferon-alpha, and the primary endpoints examined for the inhibition of gene expression (HBsAg and HBcAg) were remarkably well regulated. This suggests that the amantadine triple, or at least the double, combination had better clinical benefits than those of IFN-alpha and the nucleoside analogue single treatment. This demonstrates that the amantadine combination might be a substitute for the existing HBV therapy if the results of in vivo and in vitro studies concur.


Asunto(s)
Antivirales/farmacología , Virus de la Hepatitis B/efectos de los fármacos , Óxido Nítrico/biosíntesis , Replicación Viral/efectos de los fármacos , Amantadina/farmacología , Western Blotting , Línea Celular Tumoral , ADN Viral/biosíntesis , Dioxoles/farmacología , Sinergismo Farmacológico , Expresión Génica/efectos de los fármacos , Antígenos de Superficie de la Hepatitis B/biosíntesis , Virus de la Hepatitis B/genética , Virus de la Hepatitis B/fisiología , Humanos , Factor 3 de Genes Estimulados por el Interferón , Proteínas Mitocondriales , Proteínas/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal/efectos de los fármacos , Factores de Transcripción/genética , Transfección , Ácido Ursodesoxicólico/farmacología
20.
Arch Pharm Res ; 28(10): 1164-9, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16276974

RESUMEN

Brain microglia are phagocytic cells that are the major inflammatory response cells of the central nervous system and widely held to play important pathophysiologic roles in Alzheimer's disease (AD) in both potentially neurotoxic responses and potentially beneficial phagocytic responses. In the study, we examined whether ginsonoside Rg3, a by-product of red ginseng, enhances the microglial phagocytosis of Abeta. We found that Rg3 promoted Abeta uptake, internalization, and digestion. Increased maximal Abeta uptake was observed at 4 and 8 h after Rg3 pre-treatment (25 microg/mL), and the internalized Abeta was almost completely digested from cells within 36 h when pretreated with Rg3 comparing with single non-Rg3-treated groups. The expression of MSRA (type A MSR) was also up-regulated by Rg3 treatment in a dose- and time-dependent manner which was coincidently identified in western blots for MSRA proteins in cytosol. These results indicate that microglial phagocytosis of Abeta may be enhanced by Rg3 and the effect of Rg3 on promoting clearance of Abeta may be related to the MSRA-associated action of Rg3. Thus, stimulation of the MSRA might contribute to the therapeutic potentials of Rg3 in microglial phagocytosis and digestion in the treatment of AD.


Asunto(s)
Ginsenósidos/farmacología , Microglía/efectos de los fármacos , Receptores Depuradores/metabolismo , Péptidos beta-Amiloides/química , Péptidos beta-Amiloides/farmacocinética , Animales , Animales Recién Nacidos , Western Blotting , Carbocianinas/química , Células Cultivadas , Relación Dosis-Respuesta a Droga , Colorantes Fluorescentes/química , Expresión Génica/efectos de los fármacos , Lipoproteínas LDL/química , Lipoproteínas LDL/farmacocinética , Ratones , Microglía/citología , Microglía/metabolismo , Microscopía Fluorescente , Fragmentos de Péptidos/química , Fragmentos de Péptidos/farmacocinética , Fagocitosis/efectos de los fármacos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Receptores Depuradores/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA